Clinical Trial Update: Mild Cognitive Impairment in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating an intervention for Parkinson's disease with mild cognitive impairment has completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Parkinson Disease

Snippet

Sponsor: University of Pennsylvania | Conditions: Parkinson's Disease, Mild Cognitive Impairment | Phase 4 | Status: COMPLETED | Results posted: 2017-04-07